| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0037 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00 |
| filingDate |
1980-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1986-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8748879cc290d1ee2b906386be098645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fec5b996e26b595b11a264b74050638a |
| publicationDate |
1986-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4585765-A |
| titleOfInvention |
17β-hydroxy-17α-methyl-5α-androstano[3,2-c]pyrazole 17-methyl ether |
| abstract |
17 beta -Hydroxy-17 alpha -methyl-5 alpha -androstano[3,2-c]pyrazole 17-methyl ether is a very potent reversible male contraceptive which has a very low degree of androgenic side effects. Upon cessation of administration fertility promptly returns. |
| priorityDate |
1978-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |